Periodic Reporting for period 1 - ConCO2rde (Training network on the conversion of CO2 by smart autotrophic biorefineries)
Reporting period: 2021-01-01 to 2022-12-31
With a growing world population, depleting fossil resources and ongoing climate change, innovative new approaches are needed to reintegrate the greenhouse gas carbon dioxide into a circular economy and provide sustainable energy and material sources for future generations. The CONCO2RDE consortium aims to harness the power of autotrophic microorganisms to use renewable energy (e.g. green hydrogen) for the accumulation of biomass directly from carbon dioxide to synthesize valuable chemicals with much lower environmental impact. CONCO2RDE will train 11 Early Stage Researchers (ESRs) in cutting-edge research projects on (i) the combination of synthetic biology with metabolic and process engineering to create an efficient pathway from carbon dioxide fixation to chemical production, (ii) the application of hydrogen-driven biotransformations using redox enzymes for the synthesis of high-value added chemicals, and (iii) the development of novel reactor concepts for gas fermentations using hydrogen, carbon dioxide and oxygen towards commercially relevant processes. Finally, CONCO2RDE aims to evaluate the potential of autotrophic biorefineries for the industrial implementation of this technology. This double degree PhD program will provide in-depth training in an interdisciplinary working environment, strengthened by transferable skills training with strong industrial participation. The objectives will be achieved through an interdisciplinary consortium of 17 leading academic and private organizations, providing the ideal environment to foster complementary expertise in synthetic biology, metabolic engineering, biocatalysis and process engineering.
Work on the development of genetic tools for strain manipulation has led to the identification of several novel physiological traits of the autotrophic bacterium that can now be manipulated to allow easier and faster genetic engineering. In addition, the newly developed genetic tools have already been used to generate several novel chassis strains, including whole-cell biocatalysts for the synthesis of N-heterocycles as precursors of pharmaceuticals, surfactants or proteins. The first phase of the project was also used to investigate optimal parameters for autotrophic cultivation in bioreactors and to develop novel reactor concepts for gas fermentations. The second phase of the project will focus on the evaluation of the novel chassis strains, their further optimization by genetic and metabolic engineering and their integration into gas fermentations with the aim of improving productivity and space-time yield.